Jørgen Hilden Selected Research

Jørgen Hilden Research Topics

Disease

15	Coronary Disease (Coronary Heart Disease) 10/2021 - 01/2006
10	Coronary Artery Disease (Coronary Atherosclerosis) 10/2021 - 01/2011
4	Myocardial Infarction 01/2017 - 04/2010
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 01/2018
3	Heart Diseases (Heart Disease) 01/2017 - 01/2006
1	Stroke (Strokes) 10/2021
1	Disease Progression 10/2021
1	Chronic Disease (Chronic Diseases) 10/2021
1	Pain (Aches) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Necrosis 01/2020
1	Inflammation (Inflammations) 11/2018
1	Unstable Angina 01/2017
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2015
1	Cytomegalovirus Retinitis 06/2014
1	Hypertension (High Blood Pressure) 07/2013
1	Lung Diseases (Lung Disease) 04/2010
1	Lyme Disease (Disease, Lyme) 04/2010
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 08/2006
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2006
1	Stomach Ulcer (Gastric Ulcer) 08/2006
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 08/2006
1	Anemia 08/2006
1	Rheumatoid Arthritis 08/2006
1	Supraventricular Tachycardia 09/2005
1	Atrial Fibrillation 09/2005
1	Sinus Tachycardia 09/2005
1	Neoplasms (Cancer) 10/2004
1	Carcinoma (Carcinomatosis) 10/2004
1	HIV Infections (HIV Infection) 04/2003
1	Cerebral Palsy (Spastic Diplegia) 06/2002
1	Asthma (Bronchial Asthma) 04/2002

Drug/Important Bio-Agent (IBA)

13	Clarithromycin (Biaxin)FDA LinkGeneric 01/2020 - 01/2006
6	Biomarkers (Surrogate Marker)IBA 10/2021 - 07/2013
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 02/2010
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 02/2011
3	OsteoprotegerinIBA 01/2020 - 11/2014
2	EndostatinsIBA 01/2020 - 01/2019
2	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 01/2020 - 01/2011
2	Cathepsin BIBA 01/2020 - 11/2018
2	C-Reactive ProteinIBA 07/2013 - 02/2011
2	Immunoglobulin G (IgG)IBA 04/2010 - 04/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2010 - 01/2008
2	AntibodiesIBA 04/2010 - 04/2010
1	Troponin T (Troponin T1)IBA 01/2020
1	Lipocalin-2IBA 01/2020
1	Collagen Type XVIII (Type XVIII Collagen)IBA 01/2019
1	Cardiovascular AgentsIBA 11/2018
1	cathepsin SIBA 11/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2018
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2018
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018
1	TroponinIBA 10/2014
1	Digoxin (Digitek)FDA LinkGeneric 07/2013
1	Natriuretic PeptidesIBA 07/2013
1	DiureticsIBA 07/2013
1	pro-brain natriuretic peptide (1-76)IBA 07/2013
1	Immunoglobulin M (IgM)IBA 04/2010
1	Immunoglobulin A (IgA)IBA 04/2010
1	AutoantibodiesIBA 08/2006
1	MacrolidesIBA 01/2006
1	Carboplatin (JM8)FDA LinkGeneric 10/2004
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2004
1	Platinum Compounds (Compounds, Platinum)IBA 10/2004
1	CA-125 Antigen (CA 125 Antigen)IBA 10/2004
1	Topotecan (Hycamtin)FDA LinkGeneric 10/2004
1	TESIBA 06/2002

Therapy/Procedure

1	Herniorrhaphy 01/2021
1	Intravenous Administration 06/2014
1	Oral Administration 06/2014
1	Secondary Prevention 04/2010
1	Catheter Ablation 09/2005
1	Drug Therapy (Chemotherapy) 10/2004
1	Condoms (Condom) 04/2003
1	Massage (Zone Therapy) 04/2002
1	Therapeutics 04/2002
1	Musculoskeletal Manipulations (Manipulative Therapy) 04/2002